• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性特发性荨麻疹中的肥大细胞数量及表型

Mast cell number and phenotype in chronic idiopathic urticaria.

作者信息

Smith C H, Kepley C, Schwartz L B, Lee T H

机构信息

Department of Allergy & Respiratory Medicine, United Medical School, Guy's Hospital, London, England.

出版信息

J Allergy Clin Immunol. 1995 Sep;96(3):360-4. doi: 10.1016/s0091-6749(95)70055-2.

DOI:10.1016/s0091-6749(95)70055-2
PMID:7560638
Abstract

BACKGROUND

Increased levels of histamine have been previously demonstrated in patients with chronic idiopathic urticaria.

OBJECTIVE

The purpose of the study was to determine whether increased numbers of mast cells are present in lesional skin from such patients.

METHODS

Mast cells have been quantified in lesional (n = 11) and nonlesional (n = 9) skin from patients with chronic idiopathic urticaria and compared with site-matched skin from healthy control subjects (n = 10). Mast cells were identified by using a sensitive, double-labeling immunohistochemical technique with specific monoclonal antibodies to mast cell tryptase and chymase and quantified under light microscopy.

RESULTS

No significant differences in mast cell numbers from lesional, nonlesional, or control skin were observed (p > 0.1, Student's t test). In both patients with urticaria and control subjects, more than 99% of cutaneous mast cells contained tryptase and chymase.

CONCLUSIONS

These data indicate that increased skin histamine in chronic idiopathic urticaria is not caused by increased mast cells and may alternatively reflect an increase in histamine content per mast cell, enhanced mast cell activation, or recruitment of basophils into skin in patients with chronic idiopathic urticaria.

摘要

背景

先前已证实在慢性特发性荨麻疹患者中组胺水平升高。

目的

本研究的目的是确定此类患者的皮损中肥大细胞数量是否增加。

方法

对慢性特发性荨麻疹患者的皮损(n = 11)和非皮损(n = 9)皮肤中的肥大细胞进行定量,并与健康对照者(n = 10)的部位匹配皮肤进行比较。使用对肥大细胞类胰蛋白酶和糜蛋白酶具有特异性的单克隆抗体的灵敏双标记免疫组织化学技术鉴定肥大细胞,并在光学显微镜下进行定量。

结果

在皮损、非皮损或对照皮肤中观察到的肥大细胞数量无显著差异(p > 0.1,学生t检验)。在荨麻疹患者和对照者中,超过99%的皮肤肥大细胞含有类胰蛋白酶和糜蛋白酶。

结论

这些数据表明,慢性特发性荨麻疹中皮肤组胺增加并非由肥大细胞增多引起,可能反映了慢性特发性荨麻疹患者每个肥大细胞中组胺含量增加、肥大细胞活化增强或嗜碱性粒细胞向皮肤募集增加。

相似文献

1
Mast cell number and phenotype in chronic idiopathic urticaria.慢性特发性荨麻疹中的肥大细胞数量及表型
J Allergy Clin Immunol. 1995 Sep;96(3):360-4. doi: 10.1016/s0091-6749(95)70055-2.
2
Mast cells and T lymphocytes in chronic urticaria.慢性荨麻疹中的肥大细胞和T淋巴细胞
Clin Exp Allergy. 1995 Apr;25(4):317-22. doi: 10.1111/j.1365-2222.1995.tb01049.x.
3
Upregulation of TNF-alpha and IL-3 expression in lesional and uninvolved skin in different types of urticaria.不同类型荨麻疹患者皮损及非皮损皮肤中TNF-α和IL-3表达上调。
J Allergy Clin Immunol. 1999 Feb;103(2 Pt 1):307-14. doi: 10.1016/s0091-6749(99)70506-3.
4
Quantitation of tryptase- and chymase-containing mast cells in cutaneous lichen planus.皮肤扁平苔藓中含类胰蛋白酶和糜蛋白酶的肥大细胞定量分析。
Acta Derm Venereol. 1991;71(5):394-8.
5
Mast cell heterogeneity in chronic idiopathic urticaria.慢性特发性荨麻疹中的肥大细胞异质性
Ann Allergy. 1990 Nov;65(5):367-73.
6
Microscopic morphology of different types of urticaria.不同类型荨麻疹的微观形态
Arch Dermatol. 1998 Jan;134(1):41-6. doi: 10.1001/archderm.134.1.41.
7
Elevations in vascular markers and eosinophils in chronic spontaneous urticarial weals with low-level persistence in uninvolved skin.在慢性自发性荨麻疹风团中,血管标志物和嗜酸性粒细胞升高,且在未受累皮肤中呈低水平持续存在。
Br J Dermatol. 2014 Sep;171(3):505-11. doi: 10.1111/bjd.12991. Epub 2014 Aug 24.
8
Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria.慢性荨麻疹中针对高亲和力IgE受体的自身抗体引起的皮肤肥大细胞活化。
J Invest Dermatol. 1996 May;106(5):1001-6. doi: 10.1111/1523-1747.ep12338544.
9
TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction.慢性特发性荨麻疹患者皮肤活检标本中的TH1/TH2细胞因子和炎症细胞:与变应原诱导的迟发性皮肤反应的比较
J Allergy Clin Immunol. 2002 Apr;109(4):694-700. doi: 10.1067/mai.2002.123236.
10
Comparison of histamine-releasing factor recovered from skin and peripheral blood mononuclear cells of patients with chronic idiopathic urticaria.慢性特发性荨麻疹患者皮肤及外周血单个核细胞中组胺释放因子的比较。
Ann Allergy Asthma Immunol. 1996 Dec;77(6):475-9. doi: 10.1016/S1081-1206(10)63353-4.

引用本文的文献

1
Evaluation of pruritus biomarkers expression in chronic spontaneous urticaria.慢性自发性荨麻疹中瘙痒生物标志物表达的评估。
Arch Dermatol Res. 2025 Apr 22;317(1):731. doi: 10.1007/s00403-025-04170-6.
2
Role of Platelet-Activating Factor in the Pathogenesis of Chronic Spontaneous Urticaria.血小板激活因子在慢性自发性荨麻疹发病机制中的作用。
Int J Mol Sci. 2024 Nov 12;25(22):12143. doi: 10.3390/ijms252212143.
3
Beyond Allergies-Updates on The Role of Mas-Related G-Protein-Coupled Receptor X2 in Chronic Urticaria and Atopic Dermatitis.
超越过敏反应——Mas 相关 G 蛋白偶联受体 X2 在慢性荨麻疹和特应性皮炎中的作用的最新进展。
Cells. 2024 Jan 25;13(3):220. doi: 10.3390/cells13030220.
4
Utilizing mast cells in a positive manner to overcome inflammatory and allergic diseases.利用肥大细胞积极克服炎症和过敏疾病。
Front Immunol. 2022 Sep 14;13:937120. doi: 10.3389/fimmu.2022.937120. eCollection 2022.
5
A Proposal for the Etiopathogenesis of Acquired Cold Urticaria: Role of Substance P, Angiotensin-Converting Enzyme and Mast Cell Chymase.获得性寒冷性荨麻疹的病因发病机制探讨:P物质、血管紧张素转换酶和肥大细胞糜蛋白酶的作用
Indian J Dermatol. 2022 Mar-Apr;67(2):205. doi: 10.4103/ijd.ijd_694_21.
6
Acute Urticaria and Anaphylaxis: Differences and Similarities in Clinical Management.急性荨麻疹与过敏反应:临床管理中的差异与相似之处
Front Allergy. 2022 Apr 15;3:840999. doi: 10.3389/falgy.2022.840999. eCollection 2022.
7
A Comprehensive Approach to Urticaria: From Clinical Presentation to Modern Biological Treatments Through Pathogenesis.全面性荨麻疹概述:从临床表现到发病机制再到现代生物治疗。
Adv Exp Med Biol. 2021;1326:111-137. doi: 10.1007/5584_2020_612.
8
Current and emerging treatments for chronic spontaneous urticaria.慢性自发性荨麻疹的现有和新兴治疗方法。
Ann Allergy Asthma Immunol. 2020 Oct;125(4):380-387. doi: 10.1016/j.anai.2019.08.465. Epub 2019 Sep 5.
9
Emerging Therapies in Chronic Spontaneous Urticaria.慢性自发性荨麻疹的新兴疗法
Allergy Asthma Immunol Res. 2019 Jul;11(4):470-481. doi: 10.4168/aair.2019.11.4.470.
10
Chronic Spontaneous Urticaria: The Devil's Itch.慢性自发性荨麻疹:恶魔的瘙痒。
J Allergy Clin Immunol Pract. 2018 Jul-Aug;6(4):1097-1106. doi: 10.1016/j.jaip.2018.04.013.